(Press-News.org) Chemotherapy for patients with end-stage cancer was associated with worse quality of life near death for patients with a good ability to still perform many life functions, according to an article published online by JAMA Oncology.
Physicians have voiced concerns about the benefits of chemotherapy for patients with cancer who are nearing death. An American Society of Clinical Oncology (ASCO) expert panel has called chemotherapy use among patients for whom there was no evidence of clinical value the most widespread, wasteful and unnecessary practice in oncology.
Holly G. Prigerson, Ph.D., of Weill Cornell Medical College, New York Presbyterian Hospital, New York, and colleagues examined the association between chemotherapy use and quality of life near death as a function of patients' performance status, which ranks their ability to perform activities such as be ambulatory, do work and handle self-care.
Chemotherapy use (158 patients were receiving it at study enrollment or 50.6 percent) and performance status were assessed at baseline (a median of about four months before death) and 312 patients with progressive metastatic cancer were followed. The majority of patients were men and the average age of patients was 58.6 years.
Study results showed that chemotherapy was not associated with improved quality of life near death for patients with moderate or poor ability to perform functions. But chemotherapy was associated with worse quality of life near death compared with nonuse of chemotherapy for patients with a good ability to still perform life functions.
"Not only did chemotherapy not benefit patients regardless of performance status, it appeared most harmful to those patients with good performance status. ASCO guidelines regarding chemotherapy use in patients with terminal cancer may need to be revised to recognize the potential harm of chemotherapy use in patients with progressive metastatic disease," the study concludes.
(JAMA Oncol. Published online July 23, 2015. doi:10.1001/jamaoncol.2015.2378. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: This research was supported by a variety of grants. Authors also made conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Commentary: Chemotherapy Near the End of Life
In a related commentary, Charles D. Blanke, M.D., and Erik. K. Fromme, M.D., of the Oregon Health & Science University, Portland, write: "These data from Prigerson and associates suggest that equating treatment with hope is inappropriate. Even when oncologists communicate clearly about prognosis and are honest about the limitations of treatment, many patients feel immense pressure to continue treatment. ... At this time, it would not be fitting to suggest guidelines must be changed to prohibit chemotherapy for all patients near death without irrefutable data defining who might actually benefit, but if an oncologist suspects the death of a patient in the next six months, the default should be no active treatment," the author concludes.
(JAMA Oncol. Published online July 23, 2015. doi:10.1001/jamaoncol.2015.2379. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
INFORMATION:
Media Advisory: To contact corresponding author Holly G. Prigerson, Ph.D., call Jen Gundersen at 646-317-7402 or email jeg2034@med.cornell.edu. To contact corresponding commentary author Charles D. Blanke, M.D., call Elisa Williams at 503-494-8231 or email willieli@ohsu.edu.
To place an electronic embedded link in your story: Links will be live at the embargo time: http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.2378 and http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.2379
PHILADELPHIA - Physicians in training are twice as likely to order a costly brand-name statin (used to lower blood cholesterol levels) when supervised by senior physicians who prefer those medications in their own practice, according to a new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and published online in the Journal of General Internal Medicine. These findings document a link between low-value prescribing and graduate medical training, which physicians undergo after completing medical school but before they can practice ...
If oxygen was a driver of the early evolution of animals, only a slight bump in oxygen levels facilitated it, according to a multi-institutional research team that includes a Virginia Tech geoscientist.
The discovery, published Wednesday in the journal Nature, calls into question the long held theory that a dramatic change in oxygen levels might have been responsible for the appearance of complicated life forms like whales, sharks, and squids evolving from less complicated life forms, such as microorganisms, algae, and sponges.
The researchers discovered oxygen levels ...
JACKSONVILLE, Fla. -- In their bid to find the best combination of therapies to treat anaplastic thyroid cancer (ATC), researchers on Mayo Clinic's Florida campus demonstrated that all histone deacetylase (HDAC) inhibitors are not created equal.
In testing multiple HDAC inhibitors in combination with the chemotherapy drug paclitaxel, known to give some benefit for this aggressive cancer, they found that class II HDAC inhibitors signal through a newly discovered pathway to promote synergy with chemotherapy treatment.
They say their study, published online today in Endocrine ...
WASHINGTON, July 23, 2015 -- Have you ever wished you could hide under an invisibility cloak like Harry Potter or conceal your car with a Klingon cloaking device like in Star Trek? In a special Thursday bonus episode of Reactions, we celebrate the International Year of Light by exploring the science behind light, sight and invisibility. Though we can't make ourselves invisible yet, some promising research may light the way - or rather, bend the light away. Check it out here: https://youtu.be/sN70Bgm_PAQ.
This episode of Reactions was produced in collaboration with the ...
HANOVER, N.H. - Potentially destructive high-energy electrons streak into Earth's atmosphere from space, not as Shakespeare's "gentle rain from heaven," but at velocities approaching the speed of light.
This particle onslaught can lead to ozone depletion and damage to the orbital satellites that provide us with the navigation, communication, weather, and military-recognizance information upon which we have become increasingly dependent. These satellites fly through the Van Allen radiation belts -- giant concentric layers of charged particles held in place by the Earth's ...
A new guideline for the nutrition of management gastrointestinal symptoms in children with autism spectrum disorders (ASD) provides a framework for clinicians to navigate frequently seen issues such as food selectivity, alternative diets and nutritional deficits. The expert panel was convened at Marcus Autism Center, an affiliate of Children's Healthcare of Atlanta and the resulting guideline was published online by the Journal of the Academy of Nutrition and Dietetics (JAND).
"Children with autism are at increased risk for feeding and gastrointestinal (GI) concerns compared ...
PROVIDENCE, R.I. [Brown University] -- Brown University computer scientists have developed a new interactive tool to help researchers and clinicians explore the genetic underpinnings of cancer.
The tool -- dubbed MAGI, for Mutation Annotation and Genome Interpretation -- is an open-source web application that enables users to search, visualize, and annotate large public cancer genetics datasets, including data from The Cancer Genome Atlas (TCGA) project.
"The main motivation for MAGI has been to reduce the computational burden required for researchers or doctors to ...
How much does diet affect the cancer patient? Do "antioxidants" really play an important role in health - or are they causing more cancers than they cure? And what exactly is the relationship between obesity and cancer?
The latest Special Issue in ecancermedicalscience collects four original articles from experts in cancer and metabolism, addressing the hottest areas of research in this rapidly developing field.
"In our clinical practice, cancer patients often ask 'Doctor, is there something specific I should eat or avoid eating?'" says Guest Editor of this Special ...
The brain's effect on other parts of the body has been well established. Now, a group that includes two University of Florida Health researchers has found that it's a two-way street: Body fat can send a signal that affects the way the brain deals with stress and metabolism.
While the exact nature of those signals remains a mystery, researchers say simply knowing such a pathway exists and learning more about it could help break a vicious cycle: Stress causes a desire to eat more, which can lead to obesity. And too much extra fat can impair the body's ability to send a ...
Many of the same genes may affect GCSE results across a broad range of subjects according to a new study from the Institute of Psychiatry, Psychology & Neuroscience at King's College London.
The research, published today in Scientific Reports, also suggests that educational achievement at GCSE is highly heritable, with over half of the difference between results potentially due to inherited differences in DNA.
Previous studies have shown that academic achievement in the core subjects of English, mathematics and science at GCSE may be influenced by the same genetic traits. ...
